ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,304 | +18.0% | 9,509 | +33.7% | 0.00% | 0.0% |
| Q2 2023 | $16,358 | +54426.7% | 7,112 | -27.4% | 0.00% | 0.0% |
| Q1 2023 | $30 | -14.3% | 9,792 | -33.9% | 0.00% | 0.0% |
| Q4 2022 | $35 | -99.8% | 14,818 | +39.2% | 0.00% | – |
| Q3 2022 | $21,000 | -51.2% | 10,648 | -33.5% | 0.00% | -100.0% |
| Q2 2022 | $43,000 | +38.7% | 16,023 | +51.5% | 0.00% | – |
| Q1 2022 | $31,000 | +82.4% | 10,573 | +129.3% | 0.00% | – |
| Q4 2021 | $17,000 | -32.0% | 4,610 | -20.0% | 0.00% | -100.0% |
| Q3 2021 | $25,000 | -3.8% | 5,762 | -33.0% | 0.00% | 0.0% |
| Q2 2021 | $26,000 | +73.3% | 8,606 | +93.5% | 0.00% | – |
| Q1 2021 | $15,000 | -6.2% | 4,448 | -2.8% | 0.00% | – |
| Q4 2020 | $16,000 | +14.3% | 4,578 | +4.0% | 0.00% | – |
| Q3 2020 | $14,000 | -33.3% | 4,403 | -61.2% | 0.00% | -100.0% |
| Q2 2020 | $21,000 | +75.0% | 11,344 | -7.3% | 0.00% | 0.0% |
| Q1 2020 | $12,000 | – | 12,243 | +12143.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 100 | -99.7% | 0.00% | -100.0% |
| Q3 2019 | $59,000 | +490.0% | 38,789 | +710.8% | 0.00% | +300.0% |
| Q2 2019 | $10,000 | -64.3% | 4,784 | -37.4% | 0.00% | -50.0% |
| Q1 2019 | $28,000 | -28.2% | 7,645 | -25.1% | 0.00% | -33.3% |
| Q4 2018 | $39,000 | +160.0% | 10,209 | +553.6% | 0.00% | +200.0% |
| Q3 2018 | $15,000 | +200.0% | 1,562 | +119.4% | 0.00% | – |
| Q2 2018 | $5,000 | -61.5% | 712 | -72.1% | 0.00% | -100.0% |
| Q1 2018 | $13,000 | -74.5% | 2,548 | -69.2% | 0.00% | -75.0% |
| Q3 2017 | $51,000 | +37.8% | 8,283 | -19.0% | 0.00% | 0.0% |
| Q2 2017 | $37,000 | +131.2% | 10,226 | +110.9% | 0.00% | +100.0% |
| Q1 2017 | $16,000 | -23.8% | 4,849 | -44.0% | 0.00% | 0.0% |
| Q4 2016 | $21,000 | +320.0% | 8,652 | +487.8% | 0.00% | – |
| Q3 2016 | $5,000 | -37.5% | 1,472 | -35.5% | 0.00% | -100.0% |
| Q2 2016 | $8,000 | -68.0% | 2,282 | -63.2% | 0.00% | -75.0% |
| Q1 2016 | $25,000 | -28.6% | 6,195 | -19.2% | 0.00% | -33.3% |
| Q4 2015 | $35,000 | +9.4% | 7,666 | +44.6% | 0.01% | +100.0% |
| Q3 2015 | $32,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |